Masafumi Koshiyama, MD, PhD. “Potential Efficacy of Anti-PD-1 or PD-L1 Antibody Treatments for Gynecologic Cancers”. Women’s Health, Nov. 2017, pp. e21 - e23, doi:10.17140/WHOJ-3-e013.